“This phenomenal donation from The Taylor Family Foundation is incredibly generous, and will make a real difference to patients with head and neck cancer,” said Professor Robert Bristow, the Chief Academic Officer of The Christie NHS Foundation Trust and Co-Director of the Cancer Research UK Manchester Centre.
“In partnership with Cancer Research UK, we aim to lead the world in establishing the clinical benefit of proton beam therapy in combination with novel cancer agents. This will be underpinned by exceptional biological and physical science, to help understand how we can personalise and best use proton therapy to improve survival outcomes and the long-term quality of life for our patients.”
Ian Taylor said: “We are delighted to be working with The Christie and Cancer Research UK to be helping delivering proton beam therapy treatment (PBT) care for all those who can benefit from this exciting new treatment. The Taylor Family Foundation passionately believes that PBT can play an important role in curing head and neck cancers as well as helping children with issues such as brain tumours. We are looking forward to a long and positive relationship with The Christie and Cancer Research UK to achieve these objectives.”
The Christie NHS Foundation Trust was the first specialist trust to be rated as ‘Outstanding’ twice (in 2016 and 2018) by the health regulator the Care Quality Commission (CQC). It referred to The Christie as ‘a leader in cancer care’ and ‘a pioneer in developing innovative solutions to cancer care.’ The CQC praised the Trust’s staff which it said ‘go the extra mile to meet the needs of patients and their families’ and that they were ‘exceptionally kind and caring.’ In 2017, the CQC rated The Christie as the best specialist trust in the country, and one of the top three trusts overall in England.
Back to HCB News
